These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12486436)

  • 21. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
    Siu CW; Lau CP; Lee WL; Lam KF; Tse HF
    Crit Care Med; 2009 Jul; 37(7):2174-9; quiz 2180. PubMed ID: 19487941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.
    Alves RJ; Geovanini GR; Brito Gd; Miguel GA; Glauser VA; Nakiri K
    Arq Bras Cardiol; 2007 Jul; 89(1):22-7. PubMed ID: 17768579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
    Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
    Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
    Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
    Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term preventive effect and safety of amiodarone in patients with paroxysmal atrial fibrillation refractory to class I antiarrhythmic agents: analysis based on patient profiles].
    Komatsu T; Horiuchi D; Nakamura S; Suzuki O; Yomogida K; Okumura K
    J Cardiol; 2005 Jan; 45(1):11-7. PubMed ID: 15700925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
    Hagens VE; Rienstra M; Van Veldhuisen DJ; Crijns HJ; Van Gelder IC
    Am J Cardiol; 2006 Oct; 98(7):929-32. PubMed ID: 16996876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study.
    Cardona F; Seide H; Cox RA; Pérez CM
    P R Health Sci J; 2003 Jun; 22(2):119-23. PubMed ID: 12866134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone therapy for atrial rhythm control: insights gained from a single center experience.
    Chandhok S; Schwartzman D
    J Cardiovasc Electrophysiol; 2007 Jul; 18(7):714-8. PubMed ID: 17504255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.
    Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
    Thomas KL; Al-Khatib SM; Lokhnygina Y; Solomon SD; Kober L; McMurray JJ; Califf RM; Velazquez EJ
    Am Heart J; 2008 Jan; 155(1):87-93. PubMed ID: 18082495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery.
    Barnes BJ; Kirkland EA; Howard PA; Grauer DW; Gorton ME; Kramer JB; Muehlebach GF; Reed WA
    Ann Thorac Surg; 2006 Oct; 82(4):1332-7. PubMed ID: 16996929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.
    Nilsson KR; Al-Khatib SM; Zhou Y; Pieper K; White HD; Maggioni AP; Kober L; Granger CB; Lewis EF; McMurray JJ; Califf RM; Velazquez EJ
    Heart; 2010 Jun; 96(11):838-42. PubMed ID: 20406769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
    Naji F; Suran D; Kanic V; Vokac D; Sabovic M
    Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.